{
    "version": "2024072501",
    "title": "Corrigan Minehan Heart Center",
    "description": "A team of world-class physicians and nurses, each specializing in specific forms of heart disease, work closely together to offer leading treatments and preventive care for both common and complex cardiac conditions. Learn More >",
    "aboutPageTitle": "About the Corrigan Minehan Heart Center",
    "aboutPageHTML": "<p>At the Corrigan Minehan Heart Center at Massachusetts General Hospital, world-class specialist physicians and nurses offer leading treatments and preventative care for both common and complex cardiac conditions.</p><hr/><h3>Cross-Specialty Cardiac Care</h3><p>A dedicated team of cardiologists, cardiac surgeons, cardiac anesthesiologists, cardiac nurses and cardiac radiologists provide leading cardiac care. Our clinicians are some of the world’s foremost experts in diagnosing, treating and preventing heart disease. Each of our 11 condition-specific programs offers a team approach to diagnosis and treatment that involves a multidisciplinary team of physicians who specialize in a particular type of heart condition.</p><hr/><h3>Excellence in Cardiac Care Since 1916</h3><p>In 1916 Massachusetts General Hospital opened one of the first dedicated cardiac units in the nation. Since then, we have made significant contributions to cardiology, including:</p><ul><li>Developing the first-of-its-kind heart monitor to detect and treat arrhythmias</li><li>Investigating ways to dissolve blood clots in the coronary arteries of patients with acute myocardial infarction (heart attack)</li><li>Pioneering the development of pacemakers</li><li>Developing minimally invasive techniques, such as opening narrowed heart valves with balloons and closing heart defects with catheters</li></ul><p>We are also an international referral center for complex cases, such as:</p><ul><li><strong>Thoracic aortic disease.</strong> The Corrigan Minehan Heart Center’s Thoracic Aortic Center is one of the largest of its kind in New England and brings together specialists from cardiology, cardiac surgery, vascular and endovascular surgery and imaging</li><li><strong>Cardiac resynchronization therapy.</strong> Physicians in the Cardiac Resynchronization Therapy Program are developing new ways to treat heart failure patients, including applying remote monitoring technology</li><li><strong>Hypertrophic cardiomyopathy.</strong> Our program's physicians have treated more than 500 patients with hypertrophic cardiomyopathy, a rare condition characterized by an abnormal thickening of the muscle in the heart’s left ventricle. Learn about the Hypertrophic Cardiomyopathy Program.</li></ul><h3>Nationally Recognized Research</h3><p>Corrigan Minehan Heart Center physicians participate in nationally recognized research and clinical trials that focus on:</p><ul><li>Defining genetic indicators for coronary artery disease, atrial fibrillation and cardiomyopathy that predict future cardiovascular events in otherwise healthy individuals</li><li>Developing and evaluating new treatments, such as percutaneous heart valve replacement and endovascular stent-graft repairs</li><li>Discovering stem cells that help regenerate heart muscle and might make it possible to one day create a completely new heart. </li></ul>",
"serviceList" : [
    {
        "serviceId" : "ecmo",
        "serviceTitle": "ECMO",
        "serviceDescription": "Extracorporeal Life Support (ECLS/ECMO)",
        "servicePhone": "617-555-1212",
        "serviceImageAssetPath": "assets/images/ecmo.jpg",
        "serviceInfoPageList" : [
            {
                "serviceInfoPageTitle" : "Checklist", 
                "serviceInfoPageHTML" : "<!DOCTYPE html><html><head>\r\n    <meta charset=\"UTF-8\">\r\n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\">\r\n    <link rel=\"preconnect\" href=\"https://fonts.googleapis.com\">\r\n<link rel=\"preconnect\" href=\"https://fonts.gstatic.com\" crossorigin>\r\n<link href=\"https://fonts.googleapis.com/css2?family=Roboto+Slab:wght@100..900&family=Roboto:ital,wght@0,100;0,300;0,400;0,500;0,700;0,900;1,100;1,300;1,400;1,500;1,700;1,900&display=swap\" rel=\"stylesheet\">\r\n    <style type=\"text/css\">\r\n      @media (prefers-color-scheme: light) {body {color: #1a1b21;}}\r\n      @media (prefers-color-scheme: dark) {body {color: white;}}\r\n      body {margin-left: 1rem; margin-right: 1rem;}\r\n      p, ul {font-family: Roboto, sans-serif; font-size: .9rem;line-height: 1.5rem; letter-spacing: .05rem;}\r\n    </style>\r\n</head>\r\n<body>\r\n<p>When calling, please provide:</p>\r\n<ul>\r\n  <li>Name, DOB, height, weight</li>\r\n  <li>Admission Diagnosis</li>\r\n  <li>Recent cardiac arrest?</li>\r\n  <li>Currently on ECMO? VA, VV, or VAV ECMO?\r\n    <ul>\r\n      <li>Circuit type and flow (target 2 at minimum - goal 2.4L/min/M2); any difficulty maintaining flow</li>\r\n      <li>Cannulation details (cannula size and location, presence of distal perfusion catheter?) </li>\r\n    </ul>\r\n  </li>\r\n  <li>Current hemodynamic support\r\n    <ul>\r\n      <li>Pharmacologic: epinephrine, norepinephrine, vasopressin, milrinone, etc? dose?</li>\r\n      <li>Mechanical support: IABP, Impella, etc</li>\r\n    </ul>\r\n  </li>\r\n  <li>Last known neurologic status</li>\r\n  <li>Major comorbidities and allergies</li>\r\n  <li>All IV drips, significant medications (e.g. vasopressors, sedation, paralytics)</li>\r\n  Tubes/Lines/Drains: arterial and venous access/lines, chest tubes, etc (Note: right upper extremity for saturation and arterial line or right ear for saturation are preferred over left)\r\n  <li>Active bleeding? (anything > 100 cc/hr)</li>\r\n  <li>Mechanical ventilator settings and duration of support</li>\r\n  <li>Renal replacement therapy?</li>\r\n  <li>Most recent ABG, BMP, CBC, coagulation studies and lactate (drawn within 1 hour of transport)</li>\r\n  <li>Recent echocardiogram and imaging results (including CXR, chest CT, etc) Contact information for patient’s health care agent</li>\r\n  <li>Receiving ECMO team member will provide:</li>\r\n  <li>Decision regarding acceptance (Note: will require call-back to sending after discussion with ECMO response team)</li>\r\n  <li>Any action/investigation recommended for optimization before transport</li>\r\n</ul>\r\n<hr/>\r\n<p>For acccepted patients:</p>\r\n<p>The referring center should contact Boston MedFlight 1-800-233-8998 (preferable) or other critical care transport (CCT) team per hospital protocol.</p>\r\n<p>Arrange for a minimum of 2 units of PRBCs to travel with patient</p>\r\n<p>If intubated, sedation and chemical paralytics recommended for transport</p>\r\n<p>Prepare and provide transport team with an adequate quantity of vasoactive drips and other continuous infusions</p>\r\n<p>If patient is being transported with perfusion from the sending facility, ensure perfusion has addressed any ECMO circuit incompatibilities with receiving center prior to transport</p>\r\n<p>Please report any change in status prior to or during transport to MD Connect at <a href=\"tel:1-617-726-3384\">1-617-726-3384</a></p>\r\n<br/><br/><br/><br/><br/>\r\n</body>\r\n</html>",
                "serviceInfoPageHeadingText" : "Call MGH ECMO Hotline at 857-310-0335 or call the operator at 617-726-2000 and page 29151"

            },
            {
                "serviceInfoPageTitle" : "Guidelines", 
                "serviceInfoPageHTML" : "<!DOCTYPE html><html><head>\r\n    <meta charset=\"UTF-8\">\r\n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\">\r\n    <link rel=\"preconnect\" href=\"https://fonts.googleapis.com\">\r\n<link rel=\"preconnect\" href=\"https://fonts.gstatic.com\" crossorigin>\r\n<link href=\"https://fonts.googleapis.com/css2?family=Roboto+Slab:wght@100..900&family=Roboto:ital,wght@0,100;0,300;0,400;0,500;0,700;0,900;1,100;1,300;1,400;1,500;1,700;1,900&display=swap\" rel=\"stylesheet\">\r\n    <style type=\"text/css\">\r\n      @media (prefers-color-scheme: light) {body {color: #1a1b21;}}\r\n      @media (prefers-color-scheme: dark) {body {color: white;}}\r\n      body {margin-left: 1rem; margin-right: 1rem; font-family: Roboto, sans-serif;}\r\n      h2 {font-size: 1.2rem;}\r\n      h3 {font-size: 1.1rem;}\r\n      h4 {font-size: 1rem;}\r\n      p, ul, ol {font-size: .9rem;line-height: 1.5rem; letter-spacing: .05rem;}\r\n    </style>\r\n</head>\r\n<body>\r\n<p>Below are general guidelines for Extracorporeal Life Support (ECLS/ECMO) used at the MGH for adult medical patients. Final decisions regarding an individual patient's inclusion/exclusion should be made by ECLS certified faculty using appropriate clinical judgment. We encourage calls to MGH to discuss individual cases.</p>\r\n<ul>\r\n  <li>Usual medical and surgical treatments have failed, and the patient is at high risk of death without mechanical circulatory support including patients who are unable to separate from cardiopulmonary bypass.</li>\r\n  <li>The patient must have a reasonable expectation of myocardial/pulmonary recovery with time OR be a candidate for consideration of a durable mechanical circulatory support device and/or transplantation.</li>\r\n  <li>The patient should not have suffered catastrophic neurologic damage. Neurologic status should be assessed via clinical exam or imaging whenever possible.</li>\r\n</ul>\r\n<hr/>\r\n<h2>Indications for VA ECMO:</h2>\r\n<ul>\r\n  <li>Inadequate tissue perfusion and shock manifesting as hypotension and low cardiac output despite volume administration, inotropes and vasopressors, and standard therapies</li>\r\n</ul>\r\n<hr/>\r\n<h2>Indications for VV ECMO:</h2>\r\n<ul>\r\n    <li>Acute respiratory failure of all causes when the risk of mortality is high as identified by a PaO2/FiO2 < 150 on FiO2 > 90%</li>\r\n    <li>Uncompensated CO2 retention PaCO2 > 60, and pH < 7.25 with inability to mechanically ventilate</li>\r\n    <li>Inability to achieve safe inflation pressures (Driving P ≤ 15 cm H2O or Pplat ≤ 30 cm HO)</li>\r\n</ul>\r\n<hr/>\r\n<h2>Common indications:</h2>\r\n<ul>\r\n  <li>Cardiogenic shock: all causes</li>\r\n  <li>Refractory VT / VF</li>\r\n  <li>Cardiac arrest without ROSC</li>\r\n  <li>Early failure post heart or lung transplant</li>\r\n  <li>Pulmonary embolism</li>\r\n  <li>Acute anaphylaxis</li>\r\n  <li>Sepsis with profound cardiac depression</li>\r\n  <li>Bridge to cardiac transplant / mech support</li>\r\n  <li>Post cardiac surgery failure (unable to wean from CPB)</li>\r\n</ul>\r\n<hr/>\r\n<h2>Common indications:</h2>\r\n<ul>\r\n  <li>Severe pneumonia or aspiration</li>\r\n  <li>ARDS</li>\r\n  <li>Acute lung failure (PGD) post transplant</li>\r\n  <li>Pulmonary contusion</li>\r\n  <li>Bridge to lung transplant</li>\r\n  <li>Toxic inhalation</li>\r\n  <li>Status asthmaticus</li>\r\n  <li>Airway obstruction, i.e. mediastinal masses • Severe air leak syndrome</li>\r\n</ul>\r\n<hr/>\r\n<h2>Absolute Contraindications to All Forms of ECMO:</h2>\r\n<ul>\r\n  <li>Non-recoverable multi-organ failure or neurologic disease</li>\r\n  <li>Unwitnessed cardiac arrest or CPR > 30 min without ROSC</li>\r\n  <li>Active severe bleeding</li>\r\n  <li>Contraindication to anticoagulation or refusal to receive blood products</li>\r\n  <li>Recent neurosurgical procedures or intracranial bleeding (within 10 days)</li>\r\n  <li>End stage liver disease or renal disease on dialysis Absolute Contraindications to VA ECMO:</li>\r\n  <li>Acute Aortic dissection</li>\r\n  <li>Severe aortic valve regurgitation</li>\r\n</ul>\r\n<h2>Relative Contraindications to ECMO:</h2>\r\n<ul>\r\n  <li>Age > 70 years</li>\r\n</ul>\r\n<h2>Absolute Contraindications to VV ECMO:</h2>\r\n<ul>\r\n  <li>Severe right or left heart failure (Consider VA ECMO)</li>\r\n  <li>BMI > 40</li>\r\n  <li>Unknown neurologic status</li>\r\n  <li>Multiple organ failure</li>\r\n  <li>Prolonged mechanical ventilation</li>\r\n  <li>Severe pulmonary hypertension in a non-transplant candidate</li>\r\n  <li>Active malignancy, graft vs. host disease or significant immunosuppression</li>\r\n</ul>\r\n<hr/>\r\n<h2>Typical Patient Profiles:</h2>\r\n<h3>Veno-Arterial ECMO (Circulatory Support)</h3>\r\n<h4>Cardiogenic Shock</h4>\r\n<ol>\r\n  <li>Cl < 2.2 L/min/m2 or SVO2 < 60% (on two inotro- pes)</li>\r\n  <li>High biventricular filling pressures: PCW > 20, CVP > 15</li>\r\n  <li>Rising lactate</li>\r\n  <li>Worsening metabolic acidosis</li>\r\n  <li>Hypotension with significant vasopressor require- ment (two or more of the following):\r\n    <ul>\r\n      <li>Norepinephrine ≥ 50 mcg/min - Vasopressin ≥ 0.04 units/min</li>\r\n      <li>Phenylephrine ≥ 100 mcg/min - Epinephrine ≥ 5 mcg/min </li>\r\n    </ul>\r\n  </li>\r\n</ol>\r\n<p><strong>Unstable arrhythmias</strong></p>\r\n<h3>Veno-venous ECMO (Lung Support)</h3>\r\n<h4>Acute Respiratory Failure</h4>\r\n<ol>\r\n  <li>Sat ≤ 88% on FiO2 100% and PEEP ≥ 15, with plateau pressure ≥ 30cmH2O</li>\r\n  <li>pH < 7.20</li>\r\n  <li>FiO2 > 70% for Lung Transplant patient</li>\r\n  <li>Normal RV/LV function</li>\r\n  <li>Minimal vasopressor/inotrope requirements</li>\r\n  <li>Paralysis, Inhaled Nitric Oxide or Epoprostenol and /or prone positioning attempted</li>\r\n</ol>\r\n<br/><br/><br/><br/><br/>\r\n</body>\r\n</html>",
                "serviceInfoPageHeadingText" : "Call MGH ECMO Hotline at 857-310-0335 or call the operator at 617-726-2000 and page 29151"
            }
        ]
    },
    {
        "serviceId" : "ad",
        "serviceTitle": "Aortic Dissection",
        "serviceDescription": "Call early in the clinical course. Calls for any patient with a potential aortic dissection are welcome.",
        "servicePhone": "617-555-1212",
        "serviceImageAssetPath": "assets/images/dissection.jpg",
        "serviceInfoPageList" : [
            {
                "serviceInfoPageTitle" : "Checklist", 
                "serviceInfoPageHeadingText" : "Call MGH Aortic Dissection Hotline at 617-724-3890 and state you are calling for an Aortic Dissection Transfer", 
                "serviceInfoPageHTML" : "<!DOCTYPE html><html><head>\r\n    <meta charset=\"UTF-8\">\r\n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\">\r\n    <link rel=\"preconnect\" href=\"https://fonts.googleapis.com\">\r\n<link rel=\"preconnect\" href=\"https://fonts.gstatic.com\" crossorigin>\r\n<link href=\"https://fonts.googleapis.com/css2?family=Roboto+Slab:wght@100..900&family=Roboto:ital,wght@0,100;0,300;0,400;0,500;0,700;0,900;1,100;1,300;1,400;1,500;1,700;1,900&display=swap\" rel=\"stylesheet\">\r\n<style type=\"text/css\">\r\n  @media (prefers-color-scheme: light) {body {color: #1a1b21;}}\r\n  @media (prefers-color-scheme: dark) {body {color: white;}}\r\n  body {margin-left: 1rem; margin-right: 1rem; font-family: Roboto, sans-serif;}\r\n  h2 {font-size: 1.2rem;}\r\n  h3 {font-size: 1.1rem;}\r\n  h4 {font-size: 1rem;}\r\n  p, ul, ol {font-size: .9rem;line-height: 1.5rem; letter-spacing: .05rem;}\r\n</style>\r\n</head>\r\n<body>\r\n  <p>Call early in the clinical course - calls for any patient with a potential aortic dissection are welcome. When calling, please provide:</p>\r\n  <ul>\r\n    <li>Patient Name and DOB</li>\r\n    <li>Diagnosis: ascending aortic dissection, descending aortic dissection, aortic aneurysm </li>\r\n    <li>Pertinent co-morbidities - See Patient Risk Factors</li>\r\n    <li>Current hemodynamic medications, mechanical ventilator settings, and neurologic exam </li>\r\n    <li>Any signs of malperfusion - See clinical findings</li>\r\n    <li>ABG, BMP, LFT, CBC, coagulation studies and lactate (drawn within 2 hours of transport) </li>\r\n    <li>Access lines and monitoring</li>\r\n    <li>Your facility's ED call back number</li>\r\n  </ul>\r\n  <h3>MGH Aortic team member will provide:</h3>\r\n  <ul>\r\n      <li>Decision regarding acceptance</li>\r\n      <li>Patient disposition: Direct to OR vs. ICU vs. Stepdown</li>\r\n      <li>Any action / investigation recommended for optimization before transport</li>\r\n  </ul>\r\n  <h3>For acccepted patients:</h3>\r\n  <ul>\r\n    <li>The referring center should contact Boston MedFlight 1-800-233-8998 (preferable) or other critical care transport (CCT) team per your hospital protocol.</li>\r\n    <li>If intubated, sedation and chemical paralytics recommended for transport</li>\r\n    <li>Prepare and provide transport team with an adequate quantity of vasoactive drips and other continuous infusions (at least 2-3 times anticipated need for transport)</li>\r\n    <li>Please report any change in status prior to or during transport to MD Connect at 1-617-726-3384 </li>\r\n  </ul>\r\n  <h3>Images:</h3>\r\n  <ul>\r\n    <li>To facilitate transfer of images so they arrive in advance of the patient, a dedicated link (LifeImage) will be sent to your Radiology Department to upload the images</li>\r\n    <li>PLEASE ALSO SEND ALL IMAGING STUDIES ON A CD WITH THE PATIENT (even if they are sent electronically via LifeImage)</li>\r\n  </ul>\r\n<br/><br/><br/><br/><br/>\r\n</body>\r\n</html>"
            },
            {
                "serviceInfoPageTitle" : "Guidelines", 
                "serviceInfoPageHeadingText" : "Call MGH Aortic Dissection Hotline at 617-724-3890 and state you are calling for an Aortic Dissection Transfer",
                "serviceInfoPageHTML" : "<!DOCTYPE html><html><head>\r\n    <meta charset=\"UTF-8\">\r\n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\">\r\n    <link rel=\"preconnect\" href=\"https://fonts.googleapis.com\">\r\n<link rel=\"preconnect\" href=\"https://fonts.gstatic.com\" crossorigin>\r\n<link href=\"https://fonts.googleapis.com/css2?family=Roboto+Slab:wght@100..900&family=Roboto:ital,wght@0,100;0,300;0,400;0,500;0,700;0,900;1,100;1,300;1,400;1,500;1,700;1,900&display=swap\" rel=\"stylesheet\">\r\n    <style type=\"text/css\">\r\n      @media (prefers-color-scheme: light) {body {color: #1a1b21;}}\r\n      @media (prefers-color-scheme: dark) {body {color: white;}}\r\n      body {margin-left: 1rem; margin-right: 1rem; font-family: Roboto, sans-serif;}\r\n      h2 {font-size: 1.2rem;}\r\n      h3 {font-size: 1.1rem;}\r\n      h4 {font-size: 1rem;}\r\n      p, ul, ol {font-size: .9rem;line-height: 1.5rem; letter-spacing: .05rem;}\r\n    </style>\r\n</head>\r\n<body>\r\n  <h2>Screening for Aortic Dissection</h2>\r\n  <h3>Presenting symptoms:</h3>\r\n  <ul>\r\n    <li>Acute, severe chest, back, or abdominal pain</li>\r\n    <li>Numbness or weakness in any limbs</li>\r\n    <li>Syncope</li>\r\n  </ul>\r\n  \r\n  <h3>Patient Risk Factors:</h3>\r\n  <ul>\r\n    <li>PMH: HTN, Smoker</li>\r\n    <li>Known aortic aneurysm</li>\r\n    <li>Family Hx of dissection</li>\r\n    <li>H/o Cocaine use</li>\r\n    <li>Recent aortic manipulation (aortic surgery, stenting, angiography, etc.)</li>\r\n    <li>Connective tissue disorders (Marfan, Loeys-Dietz, Ehlers-Danlos, Turner syndromes)</li>\r\n    <li>Bicuspid aortic valve</li>\r\n  </ul>\r\n  \r\n  <h3>Clinical Findings:</h3>\r\n  <ul>\r\n    <li>Pulse deficit (radial and/or femoral)</li>\r\n    <li>Blood pressure discrepancy between limbs (systolic BP difference > 20 mmHg)</li>\r\n    <li>Signs of stroke or paraplegia</li>\r\n    <li>New heart murmur of aortic insufficiency</li>\r\n    <li>Abdominal tenderness, bloody stool</li>\r\n    <li>Oliguria / Anuria</li>\r\n  </ul>\r\n  \r\n  \r\n  <h3>Diagnostic testing:</h3>\r\n  <ul>\r\n    <li>CTA chest/abdomen/pelvis without and with contrast (Use ECG-gating, if available)\r\n      <ul>\r\n        <li>No oral contrast is necessary</li>\r\n        <li>Look for secondary findings: Pericardial effusion, organ malperfusion</li>\r\n      </ul>\r\n    </li>\r\n    <li>12 lead ECG (signs of myocardial ischemia / ST elevation MI)</li>\r\n    <li>Labs (Lactate, D-dimer, CBC, BMP, LFTs, Coag panel, Type & Cross)</li>\r\n  </ul>\r\n  \r\n  <h3>Initial Treatment:</h3>\r\n  <ul>\r\n    <li>Keep NPO</li>\r\n    <li>Large bore IV access x 2</li>\r\n    <li>Continuous heart rate and BP monitor</li>\r\n    <li>Arterial line (if possible, do not delay transfer to insert)</li>\r\n    <li>Reverse coagulopathy if anticoagulated</li>\r\n    <li>Maintain Systolic BP between 100-120 mmHg and HR < 60\r\n      <ul>\r\n        <li>First Line anti-impulse therapy with IV betablockers: Esmolol or Labetalol infusion</li>\r\n        <li>If Beta-blocker contraindicated: Diltiazem infusion</li>\r\n        <li>For secondary BP control (once HR < 60): Nitroprusside or Clevidipine or Nicardipine infusion</li>\r\n      </ul>\r\n    </li>\r\n    <li>Pain control: Morphine prn or Dilaudid prn</li>\r\n    <li>Oxygen: maintain SpO2 ≥ 92%</li>\r\n  </ul>\r\n<br/><br/><br/><br/><br/>\r\n</body>\r\n</html>"}
        ]
    }
]
}
